Today, Nevro Corp. (NVRO) Rating Reiterate by B. Riley

Today, Nevro Corp. (NVRO) Rating Reiterate by B. Riley
Nevro Corp. (NYSE:NVRO)‘s stock had its “buy” rating reissued by investment analysts at B. Riley in a research note issued on Tuesday. They currently have a $102.00 price target on the stock. B. Riley’s price target indicates a potential upside of 18.33% from the stock’s previous close.

A number of other equities research analysts have also recently commented on NVRO. Zacks Investment Research cut shares of Nevro Corp. from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 18th. William Blair began coverage on shares of Nevro Corp. in a research report on Tuesday, July 19th. They set an “outperform” rating on the stock. Wells Fargo & Co. began coverage on shares of Nevro Corp. in a research report on Tuesday, July 12th. They set an “outperform” rating on the stock. JMP Securities increased their price objective on shares of Nevro Corp. from $90.00 to $110.00 and gave the company a “market outperform” rating in a research report on Tuesday, August 9th. Finally, Piper Jaffray Cos. began coverage on shares of Nevro Corp. in a research report on Friday, July 22nd. They set an “overweight” rating and a $98.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $92.45.

Nevro Corp. (NYSE:NVRO) traded down 1.51% during midday trading on Tuesday, hitting $86.20. 155,875 shares of the company were exchanged. The stock has a 50 day moving average of $91.36 and a 200-day moving average of $85.40. Nevro Corp. has a 1-year low of $47.07 and a 1-year high of $106.93. The stock’s market capitalization is $2.48 billion.

Nevro Corp. (NYSE:NVRO) last announced its quarterly earnings data on Monday, November 7th. The company reported ($0.14) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.40) by $0.26. The business had revenue of $60.92 million for the quarter, compared to analysts’ expectations of $58.05 million. Nevro Corp. had a negative net margin of 18.91% and a negative return on equity of 14.57%. The business’s revenue was up 295.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.70) earnings per share. Equities analysts expect that Nevro Corp. will post ($0.98) earnings per share for the current year.

In other news, VP Michael Enxing sold 1,500 shares of the firm’s stock in a transaction on Tuesday, October 4th. The shares were sold at an average price of $99.31, for a total transaction of $148,965.00. Following the sale, the vice president now directly owns 39,463 shares in the company, valued at approximately $3,919,070.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael F. Demane sold 139,514 shares of the firm’s stock in a transaction on Thursday, October 6th. The shares were sold at an average price of $97.46, for a total transaction of $13,597,034.44. Following the sale, the director now owns 532,425 shares in the company, valued at $51,890,140.50. The disclosure for this sale can be found here. Insiders own 12.10% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Franklin Resources Inc. boosted its position in Nevro Corp. by 6.7% in the first quarter. Franklin Resources Inc. now owns 1,457,000 shares of the company’s stock valued at $81,970,000 after buying an additional 91,374 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Nevro Corp. by 1.4% in the first quarter. JPMorgan Chase & Co. now owns 852,758 shares of the company’s stock valued at $47,976,000 after buying an additional 11,695 shares during the last quarter. Lord Abbett & CO. LLC boosted its position in Nevro Corp. by 127.1% in the fourth quarter. Lord Abbett & CO. LLC now owns 820,843 shares of the company’s stock valued at $55,415,000 after buying an additional 459,389 shares during the last quarter. Columbus Circle Investors boosted its position in Nevro Corp. by 127.7% in the fourth quarter. Columbus Circle Investors now owns 772,081 shares of the company’s stock valued at $52,123,000 after buying an additional 433,013 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its position in Nevro Corp. by 10.2% in the fourth quarter. Wells Fargo & Company MN now owns 582,588 shares of the company’s stock valued at $39,331,000 after buying an additional 53,684 shares during the last quarter. Hedge funds and other institutional investors own 92.97% of the company’s stock.

Nevro Corp. Company Profile

Related posts

Leave a Comment